Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generalizability Of Prophylactic ICD Benefits Questioned By CMS, Panelists

This article was originally published in The Gray Sheet

Executive Summary

CMS' reliance on the precise wording of Guidant's original national coverage determination request for expanded ICD use suggests the need for companies to tailor their requests to avoid overly broad interpretations
Advertisement

Related Content

Electronic Standards Key To Better Demographic Data In Trials – McClellan
Visudyne/PDT Treatment “More Effective” Than Placebo – MCAC
Draft Guidance On NCD MCAC Referral Has Ongoing Comment Period
Tunis Presses NIH To Share ICD Study Findings; Dollens Claims Data Irrelevant
FDA, CMS Reviewers Appraise Cost Effectiveness; ICD Decision Scrutinized
Class IV Heart Failure Patients Almost Included In MCAC Coverage Vote
MCAC Supports MADIT-II Criteria; EP Testing Scuttled As Stratification Tool
MCAC Supports MADIT-II Criteria; EP Testing Scuttled As Stratification Tool
ICD Guidelines From ACC/AHA/NASPE Embrace MADIT-II Prophylactic Use
Guidant Expects Similar 20% Penetration Of Expanded ICD Market Via MADIT
Advertisement
UsernamePublicRestriction

Register

MT017908

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel